Fact.MR’s report provides forecast and assessment on the syringes & cannulas market for the period of forecast, 2018 to 2028, and the market size has been evaluated in terms of value (US$ Mn) and volume (Million Units). A plethora of factors that impact supply & demand trends in the syringes & cannulas market have been analyzed and laborated. Scope of the report is to offer its readers with valuable intelligence so that they are able to make fact-based decisions for expansion of their businesses.
An above-average rise at 4.0% volume CAGR is foreseen for the syringes & cannulas market over the period of forecast, 2018 to 2028, by a new Fact.MR study. Pervasiveness of syringes in terms of the market volume share continues to prevail, whereas the growth rate will also remain higher for these products, compared to cannulas, through 2028.
Request Sample:
https://www.factmr.com/connectus/sample?flag=S&rep_id=2007
Needleless Connectors and Jet Injectors to Witness Gradual Penetration in Syringes and Cannulas Market
Rapid drug delivery and better outcome required for patients with chronic diseases is providing a fillip for greater investment in advanced medical technologies. Driven by the increasing preference for minimal invasion surgeries, R&D investments are focused on developing next-gen medical instruments such as needleless technologies. Needle-free jet injector delivery system is one of the trending medical technology which received first FDA approval in 2014 for PharmaJet’s injector for a flu vaccine. Further, development of needleless connectors is serving as an efficient alternative of cannulas in term of reduced microbial ingress and integrity maintenance.
Syringes and Cannulas Here-to-Stay amid Emerging Alternatives
Syringes and cannulas are the primary medical instruments used in healthcare facilities for applications ranging from normal drug injections to complex surgeries. Increasing pool of patients and number of surgeries are driving the demand for syringes and cannulas substantially. Further, increasing incidences of chronic diseases such as diabetes and HIV epidemic have fuelled the consumption of syringes and cannulas. Owing to the indispensable nature of syringes and cannulas in the healthcare sector, multiple local manufacturers have emerged in the market to address the broadening gap between demand and supply.
Browse Full Report with TOC-
https://www.factmr.com/report/2007/syringes-cannulas-market
Public Healthcare Initiatives Ensure Steady Growth of the Syringes and Cannulas Market
The syringes and cannulas market is projected to witness steady growth on the back of increasing emphasis on the use of disposable syringes to prevent spread of infectious disease. Initiatives such as NPS, multiple immunization programs and WHO’s use of Smart Syringes by national and international authorities to promote safe use of injections has, in turn, propelled the syringes and cannulas market. The initiatives are addresses at increasing penetration of safe use of syringes and cannulas and huge price differences between the distribution purchase and retail prices. For instance, the National Pharmaceutical Pricing Authority (NPPA) in India estimated a mark-up of 664% in retail prices of syringes in FQ 2018. Following the statistics, the Department of Pharmaceutical is expected to regulate the pricing. On the other hand, the government is expected to initiate use of auto-disable syringes to control spread of infection through disposable syringes.
North America has traditionally remained the most remunerative market syringes & cannulas, however emergence of Asia-Pacific excluding Japan (APEJ) as a medical tourism hub has paved abundant opportunities for syringes & cannulas manufacturers. The U.S. continues to lead the North American market for syringes & cannulas, whereas majority of APEJ’s syringes & cannulas market continues to remain consolidated in India, trailed by China. The study finds that the U.S., India, and China collectively account for nearly 45% of the overall syringes & cannulas market.
Competitive Landscape
The competitive landscape section of the syringes and cannulas market report profiles key players operating in the global syringes and cannulas landscape. The section also delivers vital information such as product portfolio, notable business strategies and revenue share of key market players. Few of the profiled players in the syringes and cannulas market include Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Edwards Lifesciences Corporation, Terumo Corporation, Medtronic Plc., and Smiths Group plc (Smiths Medical).
An above-average rise at 4.0% volume CAGR is foreseen for the syringes & cannulas market over the period of forecast, 2018 to 2028, by a new Fact.MR study. Pervasiveness of syringes in terms of the market volume share continues to prevail, whereas the growth rate will also remain higher for these products, compared to cannulas, through 2028.
Request Sample:
https://www.factmr.com/connectus/sample?flag=S&rep_id=2007
Needleless Connectors and Jet Injectors to Witness Gradual Penetration in Syringes and Cannulas Market
Rapid drug delivery and better outcome required for patients with chronic diseases is providing a fillip for greater investment in advanced medical technologies. Driven by the increasing preference for minimal invasion surgeries, R&D investments are focused on developing next-gen medical instruments such as needleless technologies. Needle-free jet injector delivery system is one of the trending medical technology which received first FDA approval in 2014 for PharmaJet’s injector for a flu vaccine. Further, development of needleless connectors is serving as an efficient alternative of cannulas in term of reduced microbial ingress and integrity maintenance.
Syringes and Cannulas Here-to-Stay amid Emerging Alternatives
Syringes and cannulas are the primary medical instruments used in healthcare facilities for applications ranging from normal drug injections to complex surgeries. Increasing pool of patients and number of surgeries are driving the demand for syringes and cannulas substantially. Further, increasing incidences of chronic diseases such as diabetes and HIV epidemic have fuelled the consumption of syringes and cannulas. Owing to the indispensable nature of syringes and cannulas in the healthcare sector, multiple local manufacturers have emerged in the market to address the broadening gap between demand and supply.
Browse Full Report with TOC-
https://www.factmr.com/report/2007/syringes-cannulas-market
Public Healthcare Initiatives Ensure Steady Growth of the Syringes and Cannulas Market
The syringes and cannulas market is projected to witness steady growth on the back of increasing emphasis on the use of disposable syringes to prevent spread of infectious disease. Initiatives such as NPS, multiple immunization programs and WHO’s use of Smart Syringes by national and international authorities to promote safe use of injections has, in turn, propelled the syringes and cannulas market. The initiatives are addresses at increasing penetration of safe use of syringes and cannulas and huge price differences between the distribution purchase and retail prices. For instance, the National Pharmaceutical Pricing Authority (NPPA) in India estimated a mark-up of 664% in retail prices of syringes in FQ 2018. Following the statistics, the Department of Pharmaceutical is expected to regulate the pricing. On the other hand, the government is expected to initiate use of auto-disable syringes to control spread of infection through disposable syringes.
North America has traditionally remained the most remunerative market syringes & cannulas, however emergence of Asia-Pacific excluding Japan (APEJ) as a medical tourism hub has paved abundant opportunities for syringes & cannulas manufacturers. The U.S. continues to lead the North American market for syringes & cannulas, whereas majority of APEJ’s syringes & cannulas market continues to remain consolidated in India, trailed by China. The study finds that the U.S., India, and China collectively account for nearly 45% of the overall syringes & cannulas market.
Competitive Landscape
The competitive landscape section of the syringes and cannulas market report profiles key players operating in the global syringes and cannulas landscape. The section also delivers vital information such as product portfolio, notable business strategies and revenue share of key market players. Few of the profiled players in the syringes and cannulas market include Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Edwards Lifesciences Corporation, Terumo Corporation, Medtronic Plc., and Smiths Group plc (Smiths Medical).
Comments
Post a Comment